OTCMKTS:PFSCF - ProMetic Life Sciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ProMetic Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $5.47 0.00 (0.00 %) (As of 11/18/2019) Add Compare Today's Range$5.47Now: $5.47▼$5.4750-Day Range$5.47MA: $5.47▼$5.4752-Week Range$5.47Now: $5.47▼$352.00VolumeN/AAverage Volume174 shsMarket Capitalization$127.44 millionP/E RatioN/ADividend YieldN/ABeta2.46 ProfileAnalyst RatingsAdvanced ChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PFSCF Previous SymbolNASDAQ:PFSCF CUSIPN/A CIKN/A Webhttp://www.prometic.com/ Phone1-450-781-0115Debt Debt-to-Equity RatioN/A Current Ratio0.95 Quick Ratio0.71Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$36.55 million Price / Sales3.49 Cash FlowN/A Price / Cash FlowN/A Book Value($67.63) per share Price / Book-0.08Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-150,730,000.00 Net Margins-894.02% Return on Equity-3,350.55% Return on Assets-67.76%Miscellaneous Employees487 Outstanding Shares23,310,000Market Cap$127.44 million Next Earnings Date4/6/2020 (Estimated) OptionableNot Optionable Receive PFSCF News and Ratings via Email Sign-up to receive the latest news and ratings for PFSCF and its competitors with MarketBeat's FREE daily newsletter. OTC:PFSCF Rates by TradingView ProMetic Life Sciences (OTCMKTS:PFSCF) Frequently Asked Questions What is ProMetic Life Sciences' stock symbol? ProMetic Life Sciences trades on the OTCMKTS under the ticker symbol "PFSCF." When is ProMetic Life Sciences' next earnings date? ProMetic Life Sciences is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for ProMetic Life Sciences. What is the consensus analysts' recommendation for ProMetic Life Sciences? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProMetic Life Sciences in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ProMetic Life Sciences. Has ProMetic Life Sciences been receiving favorable news coverage? Media headlines about PFSCF stock have trended very negative recently, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. ProMetic Life Sciences earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the next few days. View News Stories for ProMetic Life Sciences. Who are some of ProMetic Life Sciences' key competitors? Some companies that are related to ProMetic Life Sciences include Molecular Templates (MTEM), CytoDyn (CYDY), Viking Therapeutics (VKTX), Ardelyx (ARDX), Clovis Oncology (CLVS), Sinovac Biotech (SVA), OrganiGram (OGI), Axovant Sciences (AXON), Organogenesis (ORGO), Assembly Biosciences (ASMB), Aptorum Group (APM), Mallinckrodt (MNK), Arcus Biosciences (RCUS), Innate Pharma (IPHYF) and BioSpecifics Technologies (BSTC). What other stocks do shareholders of ProMetic Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProMetic Life Sciences investors own include ProMetic Life Sciences (PLI), Inovio Pharmaceuticals (INO), Protalix Biotherapeutics (PLX), ADMA Biologics (ADMA), Allena Pharmaceuticals (ALNA), Cerecor (CERC), Corbus Pharmaceuticals (CRBP), Second Sight Medical Products (EYES), Gemphire Therapeutics (GEMP) and Genocea Biosciences (GNCA). Who are ProMetic Life Sciences' key executives? ProMetic Life Sciences' management team includes the folowing people: Mr. Kenneth H. Galbraith, CEO & Director (Age 56)Mr. Bruce Pritchard, COO & Interim CFOMr. Patrick Sartore, Chief Legal Officer & Corp. Sec.Mr. Bruce Wendel, Chief Bus. Devel. Officer (Age 65)Dr. John Moran, Chief Medical Officer (Age 73) How do I buy shares of ProMetic Life Sciences? Shares of PFSCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is ProMetic Life Sciences' stock price today? One share of PFSCF stock can currently be purchased for approximately $5.47. How big of a company is ProMetic Life Sciences? ProMetic Life Sciences has a market capitalization of $127.44 million and generates $36.55 million in revenue each year. ProMetic Life Sciences employs 487 workers across the globe.View Additional Information About ProMetic Life Sciences. What is ProMetic Life Sciences' official website? The official website for ProMetic Life Sciences is http://www.prometic.com/. How can I contact ProMetic Life Sciences? ProMetic Life Sciences' mailing address is 440 Boulevard Armand-Frappier Suite 300, Laval A8, H7V 4B4. The company can be reached via phone at 1-450-781-0115 or via email at [email protected] MarketBeat Community Rating for ProMetic Life Sciences (OTCMKTS PFSCF)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 104 (Vote Outperform)Underperform Votes: 122 (Vote Underperform)Total Votes: 226MarketBeat's community ratings are surveys of what our community members think about ProMetic Life Sciences and other stocks. Vote "Outperform" if you believe PFSCF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PFSCF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/29/2020 by MarketBeat.com StaffFeatured Article: Closed-End Mutual Funds
